Natixis’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.2M | Buy |
80,777
+8,604
| +12% | +$4.35M | 0.13% | 105 |
|
|
2025
Q4 | $40.9M | Sell |
72,173
-72,107
| -50% | -$38.4M | 0.15% | 102 |
|
|
2025
Q3 | $64.5M | Buy |
144,280
+24,026
| +20% | +$11.5M | 0.3% | 53 |
|
|
2025
Q2 | $65.3M | Buy |
120,254
+28,274
| +31% | +$14.8M | 0.29% | 52 |
|
|
2025
Q1 | $45.1M | Buy |
91,980
+41,423
| +82% | +$22.9M | 0.25% | 60 |
|
|
2024
Q4 | $26.4M | Buy |
50,557
+463
| +0.9% | +$241K | 0.16% | 104 |
|
|
2024
Q3 | $24.6M | Buy |
50,094
+19,343
| +63% | +$9.01M | 0.14% | 107 |
|
|
2024
Q2 | $13.7M | Sell |
30,751
-18,955
| -38% | -$7.55M | 0.08% | 171 |
|
|
2024
Q1 | $19.8M | Buy |
49,706
+4,266
| +9% | +$1.61M | 0.1% | 154 |
|
|
2023
Q4 | $15.3M | Sell |
45,440
-54,397
| -54% | -$16.2M | 0.11% | 162 |
|
|
2023
Q3 | $29.2M | Buy |
99,837
+853
| +0.9% | +$266K | 0.22% | 98 |
|
|
2023
Q2 | $33.8M | Buy |
98,984
+78,402
| +381% | +$23.7M | 0.27% | 78 |
|
|
2023
Q1 | $5.26M | Sell |
20,582
-15,964
| -44% | -$3.93M | 0.05% | 267 |
|
|
2022
Q4 | $9.7M | Sell |
36,546
-203,705
| -85% | -$49.7M | 0.05% | 277 |
|
|
2022
Q3 | $45.1M | Buy |
240,251
+85,015
| +55% | +$18.3M | 0.21% | 81 |
|
|
2022
Q2 | $31.2M | Sell |
155,236
-138,375
| -47% | -$32.5M | 0.11% | 115 |
|
|
2022
Q1 | $88.6M | Buy |
293,611
+284,281
| +3,047% | +$83.1M | 0.31% | 60 |
|
|
2021
Q4 | $3.35M | Sell |
9,330
-36,150
| -79% | -$12.4M | 0.01% | 642 |
|
|
2021
Q3 | $5.02M | Buy |
45,480
+37,167
| +447% | +$12.5M | 0.02% | 531 |
|
|
2021
Q2 | $2.55M | Buy |
8,313
+3,645
| +78% | +$1.02M | 0.01% | 487 |
|
|
2021
Q1 | $1.15M | Sell |
4,668
-67,074
| -93% | -$16.9M | ﹤0.01% | 804 |
|
|
2020
Q4 | $19.6M | Buy |
71,742
+36,330
| +103% | +$9.02M | 0.07% | 262 |
|
|
2020
Q3 | $8.38M | Sell |
35,412
-30,693
| -46% | -$6.89M | 0.06% | 202 |
|
|
2020
Q2 | $12.6M | Buy |
+66,105
| New | +$11.8M | 0.1% | 165 |
|
|
2020
Q1 | – | Sell |
-29,478
| Closed | -$5.81M | – | 789 |
|
|
2019
Q4 | $5.81M | Buy |
+29,478
| New | +$5.52M | 0.04% | 379 |
|
|
2019
Q2 | – | Sell |
-22,218
| Closed | -$4.17M | – | 827 |
|
|
2019
Q1 | $4.17M | Sell |
22,218
-5,727
| -20% | -$1.02M | 0.03% | 402 |
|
|
2018
Q4 | $4.46M | Sell |
27,945
-32,466
| -54% | -$5.5M | 0.04% | 341 |
|
|
2018
Q3 | $11.6M | Sell |
60,411
-44,499
| -42% | -$7.9M | 0.07% | 254 |
|
|
2018
Q2 | $16.7M | Sell |
104,910
-52,113
| -33% | -$7.95M | 0.09% | 209 |
|
|
2018
Q1 | $21.6M | Buy |
157,023
+51,249
| +48% | +$7.15M | 0.13% | 166 |
|
|
2017
Q4 | $12.9M | Buy |
105,774
+34,035
| +47% | +$4.26M | 0.1% | 190 |
|
|
2017
Q3 | $8.34M | Sell |
71,739
-276,624
| -79% | -$30.1M | 0.08% | 214 |
|
|
2017
Q2 | $36.2M | Buy |
+348,363
| New | +$33.5M | 0.41% | 64 |
|
|
2017
Q1 | – | Sell |
-146,718
| Closed | -$10.3M | – | 984 |
|
|
2016
Q4 | $10.3M | Buy |
146,718
+110,124
| +301% | +$8.1M | 0.11% | 186 |
|
|
2016
Q3 | $2.95M | Buy |
36,594
+31,329
| +595% | +$2.4M | 0.03% | 243 |
|
|
2016
Q2 | $387K | Buy |
+5,265
| New | +$371K | 0.01% | 346 |
|
|
2015
Q3 | – | Sell |
-5,508
| Closed | -$297K | – | 349 |
|
|
2015
Q2 | $297K | Sell |
5,508
-20,646
| -79% | -$1.15M | ﹤0.01% | 307 |
|
|
2015
Q1 | $1.47M | Buy |
26,154
+3,267
| +14% | +$185K | 0.02% | 208 |
|
|
2014
Q4 | $1.34M | Buy |
22,887
+16,587
| +263% | +$924K | 0.02% | 203 |
|
|
2014
Q3 | $323K | Sell |
6,300
-19,800
| -76% | -$983K | 0.01% | 344 |
|
|
2014
Q2 | $1.19M | Sell |
26,100
-25,371
| -49% | -$1.12M | 0.01% | 290 |
|
|
2014
Q1 | $2.5M | Buy |
+51,471
| New | +$2.42M | 0.03% | 229 |
|
|
2013
Q4 | – | Sell |
-246,600
| Closed | -$10.3M | – | 583 |
|
|
2013
Q3 | $10.3M | Buy |
246,600
+190,800
| +342% | +$8.43M | 0.11% | 178 |
|
|
2013
Q2 | $3.14M | Buy |
+55,800
| New | +$3.07M | 0.04% | 202 |
|
Other funds holding ISRG
VCM
VPM
Natixis's ISRG Position: Q1 2026 in Review
Natixis increased its Intuitive Surgical (ISRG) stake by 12% in Q1 2026, buying an estimated $4.35M and bringing the position to 80,777 shares worth $37.2M. The position accounts for 0.13% of the portfolio, ranked #105.
Natixis first reported a position in ISRG in Q2 2013 and has held it in 44 quarters since. The position peaked at $88.6M in Q1 2022. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- Natixis held 80,777 shares of Intuitive Surgical worth $37.2M as of Q1 2026.
- Natixis bought 8,604 Intuitive Surgical shares in Q1 2026, an estimated $4.35M.
- Intuitive Surgical made up 0.13% of Natixis's portfolio in Q1 2026, its #105 holding.
- Natixis first reported a position in Intuitive Surgical in Q2 2013 and has held it in 44 quarters since.
- Natixis's Intuitive Surgical position peaked at $88.6M in Q1 2022.
- 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.